423.40
USD
-5.65
(-1.31%)
Market Open
Last updated: · Delayed 15 min
Fair value401.93Plus+5%262Price 423.40501
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Q4 FY2026 · Earnings report
EPS estimate 2.08Revenue estimate 49.38B
Elevance Health debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Elevance Health's debt to equity ratio is 0.69: total debt of 30.76B USD against shareholders' equity of 44.68B USD.
- Today
- 0.69
- Average, 5 years
- 0.70
- Low, 5 years
- 0.62
- High, 5 years
- 0.79
Debt to equity = total debt ÷ shareholders' equity = 30.76B ÷ 44.68B = 0.69
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.69 | 30.76B | 44.68B | |
| FY2025 | 31 Dec 2025 | 0.76 | 33.24B | 43.88B |
| FY2024 | 31 Dec 2024 | 0.79 | 32.70B | 41.32B |
| FY2023 | 31 Dec 2023 | 0.68 | 26.65B | 39.31B |
| FY2022 | 31 Dec 2022 | 0.71 | 25.80B | 36.24B |
| FY2021 | 31 Dec 2021 | 0.69 | 24.89B | 36.06B |
| FY2020 | 31 Dec 2020 | 0.66 | 21.84B | 33.20B |
| FY2019 | 31 Dec 2019 | 0.67 | 21.21B | 31.73B |
| FY2018 | 31 Dec 2018 | 0.67 | 19.21B | 28.54B |
| FY2017 | 31 Dec 2017 | 0.75 | 19.93B | 26.50B |
| FY2016 | 31 Dec 2016 | 0.63 | 15.73B | 25.10B |
| FY2015 | 31 Dec 2015 | 0.69 | 15.86B | 23.04B |
| FY2014 | 31 Dec 2014 | 0.62 | 15.04B | 24.25B |
| FY2013 | 31 Dec 2013 | 0.59 | 14.49B | 24.77B |
| FY2012 | 31 Dec 2012 | 0.63 | 14.98B | 23.80B |
| FY2011 | 31 Dec 2011 | 0.42 | 9.84B | 23.29B |
| FY2010 | 31 Dec 2010 | 0.38 | 8.95B | 23.81B |
| FY2009 | 31 Dec 2009 | 0.34 | 8.40B | 24.86B |
| FY2008 | 31 Dec 2008 | 0.41 | 8.84B | 21.43B |
| FY2007 | 31 Dec 2007 | 0.39 | 9.04B | 22.99B |
| FY2006 | 31 Dec 2006 | 0.29 | 7.01B | 24.58B |
| FY2005 | 31 Dec 2005 | 0.27 | 6.81B | 24.99B |
| FY2004 | 31 Dec 2004 | 0.23 | 4.43B | 19.46B |
| FY2003 | 31 Dec 2003 | 0.34 | 2.06B | 6.00B |
| FY2002 | 31 Dec 2002 | 0.31 | 1.66B | 5.36B |
| FY2001 | 31 Dec 2001 | 0.55 | 1.13B | 2.06B |
| FY2000 | 31 Dec 2000 | 0.31 | 597.50M | 1.92B |
| FY1999 | 31 Dec 1999 | 0.31 | 522.00M | 1.66B |
| FY1998 | 31 Dec 1998 | 0.18 | 301.90M | 1.70B |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.69 | 30.76B | 44.68B |
| Q2 FY2026 | 30 Jun 2026 | 0.69 | 31.04B | 44.88B |
| Q1 FY2026 | 31 Mar 2026 | 0.73 | 31.84B | 43.90B |
| Q4 FY2025 | 31 Dec 2025 | 0.76 | 33.24B | 43.88B |
| Q3 FY2025 | 30 Sept 2025 | 0.73 | 32.10B | 43.95B |
| Q2 FY2025 | 30 Jun 2025 | 0.69 | 30.19B | 43.72B |
| Q1 FY2025 | 31 Mar 2025 | 0.71 | 30.00B | 42.50B |
| Q4 FY2024 | 31 Dec 2024 | 0.79 | 32.70B | 41.32B |
| Q3 FY2024 | 30 Sept 2024 | 0.62 | 27.15B | 43.78B |
| Q2 FY2024 | 30 Jun 2024 | 0.66 | 27.69B | 42.19B |
| Q1 FY2024 | 31 Mar 2024 | 0.65 | 26.45B | 40.61B |
| Q4 FY2023 | 31 Dec 2023 | 0.68 | 26.65B | 39.31B |
| Q3 FY2023 | 30 Sept 2023 | 0.69 | 26.41B | 38.42B |
| Q2 FY2023 | 30 Jun 2023 | 0.70 | 26.74B | 38.21B |
| Q1 FY2023 | 31 Mar 2023 | 0.73 | 27.10B | 37.36B |
| Q4 FY2022 | 31 Dec 2022 | 0.71 | 25.80B | 36.24B |
| Q3 FY2022 | 30 Sept 2022 | 0.71 | 25.43B | 35.99B |
| Q2 FY2022 | 30 Jun 2022 | 0.70 | 25.24B | 35.81B |
| Q1 FY2022 | 31 Mar 2022 | 0.69 | 25.00B | 35.98B |
| Q4 FY2021 | 31 Dec 2021 | 0.69 | 24.89B | 36.06B |
| Q3 FY2021 | 30 Sept 2021 | 0.69 | 24.54B | 35.74B |
| Q2 FY2021 | 30 Jun 2021 | 0.72 | 25.05B | 34.97B |
| Q1 FY2021 | 31 Mar 2021 | 0.74 | 24.95B | 33.85B |
| Q4 FY2020 | 31 Dec 2020 | 0.66 | 21.84B | 33.20B |
| Q3 FY2020 | 30 Sept 2020 | 0.67 | 22.63B | 33.92B |
| Q2 FY2020 | 30 Jun 2020 | 0.68 | 23.30B | 34.46B |
| Q1 FY2020 | 31 Mar 2020 | 0.74 | 23.48B | 31.69B |
| Q4 FY2019 | 31 Dec 2019 | 0.67 | 21.21B | 31.73B |
| Q3 FY2019 | 30 Sept 2019 | 0.68 | 21.34B | 31.33B |
| Q2 FY2019 | 30 Jun 2019 | 0.67 | 20.52B | 30.79B |
| Q1 FY2019 | 31 Mar 2019 | 0.69 | 20.56B | 30.00B |
| Q4 FY2018 | 31 Dec 2018 | 0.67 | 19.21B | 28.54B |
| Q3 FY2018 | 30 Sept 2018 | 0.67 | 19.42B | 29.09B |
| Q2 FY2018 | 30 Jun 2018 | 0.67 | 19.29B | 28.73B |
| Q1 FY2018 | 31 Mar 2018 | 0.74 | 19.89B | 27.01B |
| Q4 FY2017 | 31 Dec 2017 | 0.75 | 19.93B | 26.50B |
| Q3 FY2017 | 30 Sept 2017 | 0.63 | 16.23B | 25.95B |
| Q2 FY2017 | 30 Jun 2017 | 0.62 | 16.29B | 26.43B |
| Q1 FY2017 | 31 Mar 2017 | 0.66 | 17.14B | 26.09B |
| Q4 FY2016 | 31 Dec 2016 | 0.63 | 15.73B | 25.10B |
| Q3 FY2016 | 30 Sept 2016 | 0.63 | 15.61B | 24.74B |
| Q2 FY2016 | 30 Jun 2016 | 0.64 | 15.57B | 24.23B |
| Q1 FY2016 | 31 Mar 2016 | 0.67 | 15.80B | 23.55B |
| Q4 FY2015 | 31 Dec 2015 | 0.69 | 15.86B | 23.04B |
| Q3 FY2015 | 30 Sept 2015 | 0.70 | 16.26B | 23.24B |
| Q2 FY2015 | 30 Jun 2015 | 0.72 | 16.63B | 23.06B |
| Q1 FY2015 | 31 Mar 2015 | 0.65 | 15.84B | 24.33B |
| Q4 FY2014 | 31 Dec 2014 | 0.62 | 15.04B | 24.25B |
| Q3 FY2014 | 30 Sept 2014 | 0.63 | 15.26B | 24.29B |
| Q2 FY2014 | 30 Jun 2014 | 0.61 | 14.80B | 24.38B |
| Q1 FY2014 | 31 Mar 2014 | 0.62 | 15.04B | 24.35B |
| Q4 FY2013 | 31 Dec 2013 | 0.59 | 14.49B | 24.77B |
| Q3 FY2013 | 30 Sept 2013 | 0.60 | 14.86B | 24.81B |
| Q2 FY2013 | 30 Jun 2013 | 0.60 | 14.84B | 24.53B |
| Q1 FY2013 | 31 Mar 2013 | 0.61 | 14.78B | 24.32B |
| Q4 FY2012 | 31 Dec 2012 | 0.63 | 14.98B | 23.80B |
| Q3 FY2012 | 30 Sept 2012 | 0.57 | 13.59B | 23.82B |
| Q2 FY2012 | 30 Jun 2012 | 0.47 | 11.15B | 23.64B |
| Q1 FY2012 | 31 Mar 2012 | 0.40 | 9.47B | 23.53B |
| Q4 FY2011 | 31 Dec 2011 | 0.42 | 9.84B | 23.29B |
| Q3 FY2011 | 30 Sept 2011 | 0.42 | 10.00B | 23.72B |
| Q2 FY2011 | 30 Jun 2011 | 0.37 | 8.85B | 24.18B |
| Q1 FY2011 | 31 Mar 2011 | 0.38 | 9.00B | 23.98B |
| Q4 FY2010 | 31 Dec 2010 | 0.38 | 8.95B | 23.81B |
| Q3 FY2010 | 30 Sept 2010 | 0.37 | 9.02B | 24.36B |
| Q2 FY2010 | 30 Jun 2010 | 0.36 | 8.55B | 23.79B |
| Q1 FY2010 | 31 Mar 2010 | 0.34 | 8.39B | 24.52B |
| Q4 FY2009 | 31 Dec 2009 | 0.34 | 8.40B | 24.86B |
| Q3 FY2009 | 30 Sept 2009 | 0.39 | 8.86B | 22.87B |
| Q2 FY2009 | 30 Jun 2009 | 0.41 | 9.17B | 22.25B |
| Q1 FY2009 | 31 Mar 2009 | 0.43 | 9.34B | 21.51B |
| Q4 FY2008 | 31 Dec 2008 | 0.41 | 8.84B | 21.43B |
| Q3 FY2008 | 30 Sept 2008 | 0.43 | 9.22B | 21.67B |
| Q2 FY2008 | 30 Jun 2008 | 0.46 | 9.77B | 21.25B |
| Q1 FY2008 | 31 Mar 2008 | 0.43 | 9.29B | 21.50B |
| Q4 FY2007 | 31 Dec 2007 | 0.39 | 9.04B | 22.99B |
| Q3 FY2007 | 30 Sept 2007 | 0.37 | 8.70B | 23.67B |
| Q2 FY2007 | 30 Jun 2007 | 0.33 | 8.17B | 24.99B |
| Q1 FY2007 | 31 Mar 2007 | 0.28 | 7.11B | 25.14B |
| Q4 FY2006 | 31 Dec 2006 | 0.29 | 7.01B | 24.58B |
| Q3 FY2006 | 30 Sept 2006 | 0.30 | 7.34B | 24.14B |
| Q2 FY2006 | 30 Jun 2006 | 0.32 | 7.47B | 23.24B |
| Q1 FY2006 | 31 Mar 2006 | 0.30 | 7.14B | 24.11B |
| Q4 FY2005 | 31 Dec 2005 | 0.27 | 6.81B | 24.99B |
| Q3 FY2005 | 30 Sept 2005 | 0.21 | 4.38B | 21.23B |
| Q2 FY2005 | 30 Jun 2005 | 0.22 | 4.62B | 20.55B |
| Q1 FY2005 | 31 Mar 2005 | 0.21 | 4.27B | 20.00B |
| Q4 FY2004 | 31 Dec 2004 | 0.22 | 4.28B | 19.46B |
| Q3 FY2004 | 30 Sept 2004 | 0.28 | 1.90B | 6.80B |
| Q2 FY2004 | 30 Jun 2004 | 0.32 | 2.09B | 6.56B |
| Q1 FY2004 | 31 Mar 2004 | 0.33 | 2.07B | 6.36B |
| Q4 FY2003 | 31 Dec 2003 | 0.34 | 2.06B | 6.00B |
| Q3 FY2003 | 30 Sept 2003 | 0.36 | 2.11B | 5.85B |
| Q2 FY2003 | 30 Jun 2003 | 0.36 | 2.04B | 5.73B |
| Q1 FY2003 | 31 Mar 2003 | 0.37 | 2.04B | 5.48B |
| Q4 FY2002 | 31 Dec 2002 | 0.31 | 1.66B | 5.36B |
| Q3 FY2002 | 30 Sept 2002 | 0.38 | 2.03B | 5.33B |
| Q2 FY2002 | 30 Jun 2002 | 0.50 | 1.12B | 2.23B |
| Q1 FY2002 | 31 Mar 2002 | 0.55 | 1.18B | 2.13B |
| Q4 FY2001 | 31 Dec 2001 | 0.55 | 1.13B | 2.06B |
| Q3 FY2001 | 30 Sept 2001 | 0.40 | 866.80M | 2.17B |
| Q1 FY2001 | 31 Mar 2001 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Current ratio,All ratios
Common questions about Elevance Health's debt to equity
Source: Financial Modeling Prep
